Amgen : AMGN

All Amgen Articles

720 Articles

Jon C. Ogg | Feb 13, 2012 at 4:17 PM EST

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. …

Paul Ausick | Feb 9, 2012 at 4:07 PM EST

24/7 Wall St. Closing Bell (AONE, EXPE, RIMM, AMGN, MMM, AAPL, CSCO, AMSC, BG, DNKN, LO, PEP, PM, SIRI, TDC, IPSU, TSL, DMND, GRPN, TLEO, CZR)

The three major US stock indexes opened a bit higher this morning, and after some volatility have managed to get…

Jon C. Ogg | Feb 9, 2012 at 8:29 AM EST

Top Analyst Upgrades & Downgrades (AMGN, AUO, AONE, ELN, EXPE, IR, MMM, MRH, NYX, POST, RIMM, SOHU, AAPL)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Paul Ausick | Feb 8, 2012 at 2:24 PM EST

Amgen Fails in Bid to Expand Use of Cancer Drug (AMGN)

A US drug advisory panel today denied by a 12-1 vote permission for Amgen Inc. (NASDAQ: AMGN) to market its…

Jon C. Ogg | Feb 8, 2012 at 7:59 AM EST

Credit Suisse Chooses Biogen Idec Over Amgen (BIIB, AMGN)

Credit Suisse is making a change in its Global Biotechnology outlook and says the is ‘room to run on generalist…

Paul Ausick | Jan 31, 2012 at 4:06 PM EST

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI number failed to…

Jon C. Ogg | Jan 31, 2012 at 8:27 AM EST

Top Analyst Upgrades & Downgrades (AMGN, AON, EQT, EXEL, IPI, ERIC, MDVN, NKE, NIHD, NYX, POT, RAX, RRC, SYMC, TSLA, UA, UNH)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Jon C. Ogg | Jan 26, 2012 at 5:08 PM EST

High-Premium Biotech M&A Continues (AMGN, CELG, MITI, IBB)

Thursday brought yet more merger and acquisition news in the ongoing buyout trends in the biotech sector. Amgen Inc. (NASDAQ: AMGN)…

Paul Ausick | Jan 23, 2012 at 4:08 PM EST

24/7 Wall St. Closing Bell (COP, SIRI, GOOG, PG, AMGN, HAL, TWIN, PETS, MFN, GDP, CBRX, SR, RIMG)

Equity markets opened slightly higher this morning but trailed off to negative territory in the late morning. By late afternoon,…

Jon C. Ogg | Jan 23, 2012 at 8:28 AM EST

Top Analyst Upgrades & Downgrades (AMGN, CMA, COP, GOOG, JIVE, JCI, NUVA, PG, PHM, RIMM, SN, SIRI, VPHM)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Paul Ausick | Jan 11, 2012 at 1:37 PM EST

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking…

Jon C. Ogg | Jan 4, 2012 at 8:01 AM EST

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at…

Paul Ausick | Dec 20, 2011 at 4:06 PM EST

24/7 Wall St. Closing Bell (T, FFIV, URBN, AMGN, BAX, CAG, GIS, NAV, SAFM, JEF, NKE, ORCL, TRGT, CIE, CSIQ, PBH, HOV, CVS)

US equity markets opened sharply higher this morning and have been able to sustain and even add to those gains…

Jon C. Ogg | Dec 20, 2011 at 8:35 AM EST

Top Analyst Upgrades & Downgrades (AMGN, T, BAX, BHP, FFIV, AWAY, M, MAA, NVLS, OPEN, SFD, URBN, WWWW)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage research calls this…

Paul Ausick | Dec 16, 2011 at 4:08 PM EST

24/7 Wall St. Closing Bell (ZNGA, AAPL, SCCO, AMGN, DFS, RIMM, DRI, STEI, HOV, ZQK, ISTA, RRR, MRT, INHX, CRYP, CIE)

US equity markets opened solidly higher this morning, but began to lose momentum by mid-morning. From there it’s been a…

1 … 37 38 39 40 41 … 48

Amgen : AMGN

All Amgen Articles

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

24/7 Wall St. Closing Bell (AONE, EXPE, RIMM, AMGN, MMM, AAPL, CSCO, AMSC, BG, DNKN, LO, PEP, PM, SIRI, TDC, IPSU, TSL, DMND, GRPN, TLEO, CZR)

Top Analyst Upgrades & Downgrades (AMGN, AUO, AONE, ELN, EXPE, IR, MMM, MRH, NYX, POST, RIMM, SOHU, AAPL)

Amgen Fails in Bid to Expand Use of Cancer Drug (AMGN)

Credit Suisse Chooses Biogen Idec Over Amgen (BIIB, AMGN)

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

Top Analyst Upgrades & Downgrades (AMGN, AON, EQT, EXEL, IPI, ERIC, MDVN, NKE, NIHD, NYX, POT, RAX, RRC, SYMC, TSLA, UA, UNH)

High-Premium Biotech M&A Continues (AMGN, CELG, MITI, IBB)

24/7 Wall St. Closing Bell (COP, SIRI, GOOG, PG, AMGN, HAL, TWIN, PETS, MFN, GDP, CBRX, SR, RIMG)

Top Analyst Upgrades & Downgrades (AMGN, CMA, COP, GOOG, JIVE, JCI, NUVA, PG, PHM, RIMM, SN, SIRI, VPHM)

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

24/7 Wall St. Closing Bell (T, FFIV, URBN, AMGN, BAX, CAG, GIS, NAV, SAFM, JEF, NKE, ORCL, TRGT, CIE, CSIQ, PBH, HOV, CVS)

Top Analyst Upgrades & Downgrades (AMGN, T, BAX, BHP, FFIV, AWAY, M, MAA, NVLS, OPEN, SFD, URBN, WWWW)

24/7 Wall St. Closing Bell (ZNGA, AAPL, SCCO, AMGN, DFS, RIMM, DRI, STEI, HOV, ZQK, ISTA, RRR, MRT, INHX, CRYP, CIE)

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn't Paid Capital-Gains Tax Since.

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Amgen : AMGN

All Amgen Articles

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

24/7 Wall St. Closing Bell (AONE, EXPE, RIMM, AMGN, MMM, AAPL, CSCO, AMSC, BG, DNKN, LO, PEP, PM, SIRI, TDC, IPSU, TSL, DMND, GRPN, TLEO, CZR)

Top Analyst Upgrades & Downgrades (AMGN, AUO, AONE, ELN, EXPE, IR, MMM, MRH, NYX, POST, RIMM, SOHU, AAPL)

Amgen Fails in Bid to Expand Use of Cancer Drug (AMGN)

Credit Suisse Chooses Biogen Idec Over Amgen (BIIB, AMGN)

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

Top Analyst Upgrades & Downgrades (AMGN, AON, EQT, EXEL, IPI, ERIC, MDVN, NKE, NIHD, NYX, POT, RAX, RRC, SYMC, TSLA, UA, UNH)

High-Premium Biotech M&A Continues (AMGN, CELG, MITI, IBB)

24/7 Wall St. Closing Bell (COP, SIRI, GOOG, PG, AMGN, HAL, TWIN, PETS, MFN, GDP, CBRX, SR, RIMG)

Top Analyst Upgrades & Downgrades (AMGN, CMA, COP, GOOG, JIVE, JCI, NUVA, PG, PHM, RIMM, SN, SIRI, VPHM)

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

24/7 Wall St. Closing Bell (T, FFIV, URBN, AMGN, BAX, CAG, GIS, NAV, SAFM, JEF, NKE, ORCL, TRGT, CIE, CSIQ, PBH, HOV, CVS)

Top Analyst Upgrades & Downgrades (AMGN, T, BAX, BHP, FFIV, AWAY, M, MAA, NVLS, OPEN, SFD, URBN, WWWW)

24/7 Wall St. Closing Bell (ZNGA, AAPL, SCCO, AMGN, DFS, RIMM, DRI, STEI, HOV, ZQK, ISTA, RRR, MRT, INHX, CRYP, CIE)

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More

Featured Reads

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn't Paid Capital-Gains Tax Since.